Target Name: MIR2115
NCBI ID: G100313840
Review Report on MIR2115 Target / Biomarker Content of Review Report on MIR2115 Target / Biomarker
MIR2115
Other Name(s): microRNA 2115 | hsa-miR-2115-3p | hsa-miR-2115-5p | hsa-mir-2115 | MicroRNA 2115

MIR2115: A Potential Drug Target and Biomarker

Molecular medicine has made significant strides in the past decade, and the discovery of MIR2115 is an exciting development in the field. MIR2115 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. In this article, we will explore the science behind MIR2115 and its potential implications for future drug development.

MIR2115: The MIR2115 Gene

MIR2115 is a non-coding RNA molecule that was identified as a potential drug target and biomarker. The molecule has a length of 211 amino acids and is located on the X chromosome. MIR2115 is unique due to its highly conserved sequence, which includes a unique N-terminus and a unique C-terminus. The conserved sequence is indicative of a potential protein-coding gene, but further analysis is needed to confirm this.

MIR2115: The Potential Drug Target

MIR2115 has been identified as a potential drug target due to its unique structure and conserved sequence. The molecule is known to interact with the protein serine kinase SIK-3, which is a known drug target for several diseases, including cancer. MIR2115 has also been shown to interact with the protein NF-kappa-B, which is involved in inflammation and cellular signaling. These interactions suggest that MIR2115 may have unique functions in cellular signaling pathways.

MIR2115: The Potential Biomarker

MIR2115 has also been identified as a potential biomarker for several diseases, including cancer. The molecule has been shown to be expressed in several types of cancer, including breast, lung, and ovarian cancer. Additionally, MIR2115 has been shown to be downregulated in cancer cells, which suggests that it may be a potential therapeutic target. Further research is needed to confirm the utility of MIR2115 as a biomarker for cancer.

MIR2115: The Future of Drug Development

The discovery of MIR2115 has significant implications for future drug development. The molecule has been shown to be a potential drug target for several diseases, including cancer. Further research is needed to confirm the utility of MIR2115 as a drug target and to develop small molecules or antibodies that can interact with MIR2115.

In conclusion, MIR2115 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. The molecule's unique structure and conserved sequence make it an attractive target for drug development. Further research is needed to confirm the utility of MIR2115 as a drug target and to develop small molecules or antibodies that can interact with the molecule. With further research, MIR2115 has the potential to revolutionize molecular medicine.

Protein Name: MicroRNA 2115

The "MIR2115 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR2115 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133